<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>UroGen Pharma Ltd.</issuerName>
    <cusip>M96088109</cusip>
    <isin>IL0011407144</isin>
    <meetingDate>08/26/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>1015363</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>1015363</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>2</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>UroGen Pharma Ltd.</issuerName>
    <cusip>M96088109</cusip>
    <isin>IL0011407144</isin>
    <meetingDate>08/26/2025</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>129936</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>129936</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>1</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>UroGen Pharma Ltd.</issuerName>
    <cusip>M96088111</cusip>
    <isin>IL0011407146</isin>
    <meetingDate>06/22/2026</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers, as disclosed in the accompanying proxy statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>1025666</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>1025666</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>2</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>UroGen Pharma Ltd.</issuerName>
    <cusip>M96088111</cusip>
    <isin>IL0011407146</isin>
    <meetingDate>06/22/2026</meetingDate>
    <voteDescription>To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers, as disclosed in the accompanying proxy statement.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>119663</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>119663</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>1</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>Teva Pharmaceutical Industries Limited</issuerName>
    <cusip>881624209</cusip>
    <isin>US8816242098</isin>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>18387665</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>18387665</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>2</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>Teva Pharmaceutical Industries Limited</issuerName>
    <cusip>881624209</cusip>
    <isin>US8816242098</isin>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>35241870</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>35241870</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>1</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>Teva Pharmaceutical Industries Limited</issuerName>
    <cusip>881624209</cusip>
    <isin>US8816242098</isin>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs).</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>307667</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>307667</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
  <proxyTable>
    <issuerName>Mobileye Global Inc.</issuerName>
    <cusip>60741F104</cusip>
    <isin>US60741F1049</isin>
    <meetingDate>06/18/2026</meetingDate>
    <voteDescription>Advisory vote on executive compensation.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>738667</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>AGAINST</howVoted>
        <sharesVoted>738667</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>2</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>Ormat Technologies, Inc.</issuerName>
    <cusip>686688102</cusip>
    <isin>US6866881021</isin>
    <meetingDate>06/02/2026</meetingDate>
    <voteDescription>To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>857835</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>857835</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>2</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>Ormat Technologies, Inc.</issuerName>
    <cusip>686688102</cusip>
    <isin>US6866881021</isin>
    <meetingDate>06/02/2026</meetingDate>
    <voteDescription>To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>100716</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>100716</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>1</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>Ormat Technologies, Inc.</issuerName>
    <cusip>686688102</cusip>
    <isin>US6866881021</isin>
    <meetingDate>06/02/2026</meetingDate>
    <voteDescription>To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>29975</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>29975</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
  </proxyTable>
</proxyVoteTable>
